Renaissance Technologies’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $139K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $392K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $57K | Sell |
|
|||||
|
2023
Q2 | $125K | Buy |
|
|||||
|
2023
Q1 | $82K | Buy |
|
|||||
|
2022
Q4 | $80K | Buy |
|
|||||
|
2022
Q3 | $59K | Buy |
|
|||||
|
2022
Q2 | $67K | Buy |
|
|||||
|
2022
Q1 | $87K | Buy |
|
|||||
|
2021
Q4 | $80K | Sell |
|
|||||
|
2021
Q3 | $414K | Sell |
|
|||||
|
2021
Q2 | $1.2M | Buy |
|
|||||
|
2021
Q1 | $1.44M | Buy |
|
|||||
|
2020
Q4 | $563K | Sell |
|
|||||
|
2020
Q3 | $547K | Sell |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2020
Q1 | $309K | Buy |
|
|||||
|
2019
Q4 | $448K | Buy |
|
|||||
|
2019
Q3 | $354K | Buy |
|
|||||
|
2019
Q2 | $268K | Buy |
|
|||||
|
2019
Q1 | $133K | Sell |
|
|||||
|
2018
Q4 | $88K | Sell |
|
|||||
|
2018
Q3 | $176K | Buy |
|